SelectScience InterviewsDrug discovery > Pre-Clinical Development
How critical insights from imaging mass cytometry are transforming precision medicine
2021-Fluidigm-olivierelemento-V_1.txt
6 Jan 2022In this video, Olivier Elemento, Professor of Physiology and Biology at Weill Cornell Medicine and Director of the Englander Institute for Precision Medicine, provides expert insight into why artificial intelligence, high-throughput sequencing, and imaging mass cytometry are becoming increasingly critical tools for personalizing treatments and improving patient outcomes. Elemento also describes the integral role of the Hyperion™ Imaging System by Fluidigm Corporation in his work with diseases from COVID-19 to cancer.